Nykaa Delivers INR 11,800 Crore GMV in FY25
Falguni Nayar, executive chairperson, founder & CEO of Nykaa, said the company's beauty business had grown fivefold over the past five years, while its fashion vertical expanded twentyfold
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Nykaa, one of India's leading beauty and lifestyle retailers, outlined its long-term growth strategy at its annual investor day 2025, emphasizing resilience and expansion despite headwinds in the broader e-commerce space. The update was shared via a press release by the company.
While sector-wide growth has moderated, Nykaa reported strong performance across all its verticals (beauty, fashion, and B2B distribution) highlighting a multi-pronged strategy designed to keep pace with India's evolving consumer market. The company's gross merchandise value (GMV) reached INR 11,800 crore in FY25, posting a five-year compound annual growth rate (CAGR) of 36 per cent.
Falguni Nayar, executive chairperson, founder & CEO of Nykaa, said the company's beauty business had grown fivefold over the past five years, while its fashion vertical expanded twentyfold. "Even in a cautious macro, we've continued to grow with discipline and purpose. Beauty remains a powerhouse, our B2B play is scaling well, and we see recovering momentum in fashion," Nayar stated.
India's retail and e-commerce sectors are undergoing a digital transformation, with lifestyle segments expected to play a key role. The country's e-commerce market is projected to touch $170–190 billion by FY30, with beauty and fashion contributing over one-third of this growth. Nykaa, which claims a 30 per cent+ share of the online beauty and personal care market, has positioned itself at the heart of this shift.
The company also pointed to the rising influence of Gen Z, which now accounts for 44 per cent of spending in beauty and personal care on its platform. "India is now on every global beauty company's radar," Nayar noted, citing the acceleration of premiumization and digital discovery. Global brands such as CHANEL, YSL, and NARS are among the fastest-growing on Nykaa.
On the fashion front, Nykaa Fashion posted INR 3,800 crore in GMV for FY25, supported by a growing portfolio of over 4,500 brands and a sharp focus on high-value customers. With an average order value roughly twice the industry standard, the fashion arm is aiming for three to fourfold growth over the next five years, targeting an eventual EBITDA margin of around 10 per cent.
Meanwhile, the House of Nykaa, a portfolio of in-house consumer brands, crossed INR 2,100 crore in GMV in FY25. Five of its brands surpassed INR 100 crore in GMV, including three that exceeded INR 200 crore, underscoring the company's growing presence in direct-to-consumer segments.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
an hour ago
- Fast Company
Big Lots new store openings come with a warning for online shoppers: Don't fall for scam websites
Big Lots has been through a wild ride since the home discount retail chain filed for Chapter 11 bankruptcy protection last September. In December 2024, the company announced that it would hold going-out-of-business sales at its remaining store locations. The following month, however, Big Lots announced that Variety Wholesalers—a retail company based in North Carolina—would acquire and operate hundreds of existing Big Lots stores. After a period of remodeling and restocking, Variety Wholesalers has since reopened 219 Big Lots stores in a handful of states. The openings took place in four waves, starting in April and ending in June. The final reopening phase concluded with the reopening of 78 Big Lots stores on June 5. While return of Big Lots is good news for fans of the brand, it may be exposing some unsuspecting bargain hunters to scams—particularly, for shoppers who prefer to buy things online. Big Lots warns of online scams Earlier this month, Big Lots took to social media to alert customers about the presence of online scams, explaining that its current website has no e-commerce component. 'BIG LOTS! no longer operates any ecommerce website,' the retailer wrote on its Facebook page. 'These are scam websites using our name and logo. Any purchases made through these websites should be IMMEDIATELY reported to your bank or credit card company. Our official website is The post attracted hundreds of comments, with some commenters saying they'd fallen victim to the bogus offers. Scammers have been targeting consumers with online ads impersonating Big Lots. Links within these ads direct hopeful shoppers to fake websites that are not affiliated with the official retailer. Be aware that any advertisements promoting online Big Lots deals are not legitimate. Some products are still listed on the official Big Lots website A section of the retailer's official website highlights products that Big Lots stores actually sell. Although there are no capabilities to make a purchase through the official Big Lots website, product listings include photos, descriptions, and prices. Jeff King, vice president of sales and marketing for Variety Wholesalers, told Fast Company that the products listed on the Big Lots website are meant to illustrate the deals available in-store. 'We do have products listed on our website to show the great values on the large variety of products we carry in our stores,' he said. 'We do this to encourage customers to visit our stores and see what deals they can find.' Bottom line: It's essential to be vigilant against online shopping scams. If you're hoping to shop at Big Lots, you'll need to visit a physical store.
Yahoo
an hour ago
- Yahoo
Sugar Prices Tumble on an Expected Global Sugar Surplus
July NY world sugar #11 (SBN25) today is down -0.38 (-2.38%), and August London ICE white sugar #5 (SWQ25) is down -0.80 (-0.17%). Sugar prices today extended their three-month-long selloff, with NY sugar dropping to a 4-year nearest-futures low. Sugar prices have been under pressure over the past three months due to expectations of a global sugar surplus. On May 22, the USDA, in its biannual report, projected that global 2025/26 sugar production would increase by +4.7% y/y to a record 189.318 million metric tons (MMT), with a global sugar surplus of 41.188 MMT, up 7.5% year-over-year. Coffee Prices Extend 2-week Plunge as Frost Risks Recede in Brazil West African Cocoa Crop Optimism Weighs on Prices Sugar Prices Boosted by Strength in Crude Oil Prices Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! The outlook for higher sugar production in India, the world's second-largest producer, is bearish for prices. On June 2, India's National Federation of Cooperative Sugar Factories projected that India's 2025/26 sugar production would climb +19% y/y to 35 MMT, citing larger planted cane acreage. The outlook for abundant rainfall in India could lead to a bumper sugar crop, which is bearish for prices. On April 15, India's Ministry of Earth Sciences projected an above-normal monsoon this year, with total rainfall forecast to be 105% of the long-term average. India's monsoon season runs from June through September. Signs of larger global sugar output are negative for prices. On May 22, the USDA's Foreign Agricultural Service (FAS) predicted that Brazil's 2025/26 sugar production would rise +2.3% y/y to a record 44.7 MMT. Also, India's 2025/26 sugar production is projected to rise +25% y/y to 35.3 MMT, citing favorable monsoon rains and increased sugar acreage. In addition, Thailand's 2025/26 sugar production is expected to climb +2% y/y to 10.3 MMT. In a bearish factor, the Indian government said on January 20 that it would allow its sugar mills to export 1 MMT of sugar this season, easing the restrictions placed on sugar exports in 2023. India has restricted sugar exports since October 2023 to maintain adequate domestic supplies. India allowed mills to export only 6.1 MMT of sugar during the 2022/23 season to September 30, after allowing exports of a record 11.1 MMT in the previous season. However, the ISMA projects that India's 2024/25 sugar production will fall -17.5% y/y to a 5-year low of 26.2 MMT. Also, the ISMA reported last Monday that India's sugar production from Oct 1-May 15 was 25.74 MMT, down -17% from the same period last year. In addition, Indian Food Secretary Chopra said on May 1 that India's 2024/25 sugar exports may only total 800,000 MT, below earlier expectations of 1 MMT. The outlook for higher sugar production in Thailand is bearish for sugar prices. On May 2, Thailand's Office of the Cane and Sugar Board reported that Thailand's 2024/25 sugar production rose +14% y/y to 10.00 MMT. Thailand is the world's third-largest sugar producer and the second-largest exporter of sugar. A positive factor for sugar prices is the expected increase in sugar imports from Pakistan, following the Pakistani government's announcement last Friday that it plans to import 250,000 metric tons of raw sugar due to a disappointing sugarcane harvest. Sugar prices have some support from reduced sugar production in Brazil. Unica reported last Monday that the cumulative 2025/26 Brazil Center-South sugar output through May is down by -11.6% y/y to 6.954 MMT. Last month, Conab, Brazil's government crop forecasting agency, said 2024/25 Brazil sugar production fell -3.4% y/y to 44.118 MMT, citing lower sugarcane yields due to drought and excessive heat. The International Sugar Organization (ISO) raised its 2024/25 global sugar deficit forecast to a 9-year high of -5.47 MMT on May 15, up from a February forecast of -4.88 MMT. This indicates a tightening market following the 2023/24 global sugar surplus of 1.31 MMT. ISO also cut its 2024/25 global sugar production forecast to 174.8 MMT from a February forecast of 175.5 MMT. The USDA, in its bi-annual report released May 22, projected that global 2025/26 sugar production would climb +4.7% y/y to a record 189.318 MMT and that global 2025/26 human sugar consumption would increase +1.4% y/y to a record 177.921 MMT. The USDA also forecasted that 2025/26 global sugar ending stocks would climb +7.5% y/y to 41.188 MMT. On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Novo Nordisk's $50 Obesity Shot Hits India -- The Drug War Just Got Real
Novo Nordisk (NYSE:NVO) is making a strategic move into one of the world's fastest-growing obesity markets by launching its blockbuster weight-loss drug Wegovy in India. Priced at just over $50 per week for the starting dose, the company is introducing all five dosage strengths under a locally tailored pricing strategy. At the high end, the 2.4 mg injection comes in at ?6,503.75still well below the U.S. price of $337.25, but nearly double the cost of Eli Lilly's (NYSE:LLY) Mounjaro, which entered the Indian market in March. Management emphasized that the rollout is focused on long-term chronic weight management and cardiovascular risk reduction, with supply being fully imported for now. Warning! GuruFocus has detected 1 Warning Sign with NVO. India presents a compelling growth opportunity. With over 80 million obese individualsprojected to reach 450 million by 2050the country is becoming a central front in the global battle against obesity and related diseases. Novo Nordisk's timing coincides with growing medical endorsements for semaglutide, including the recent recommendation by the American College of Cardiology for cardiovascular use. The company is working closely with distribution partners to ensure responsible access, particularly in urban centers where demand is expected to be strongest. In addition, Novo's India head highlighted efforts to prevent off-label cosmetic use and to collaborate with insurers and financing providers to improve affordability. While Wegovy's commercial push in India is just beginning, Novo is already thinking several steps ahead. Patent protections on semaglutide are set to expire in early Q2 2026, and Indian pharma companies like Sun Pharma, Cipla, and Dr. Reddy's are already preparing generics. Novo plans to respond by accelerating its next-gen pipeline, including obesity candidates like CagriSema and amycretin, which are currently in trials. As Wegovy gains traction, Novo's longer-term success in India could hinge not only on pricing and access, but also on its ability to stay ahead of the innovation curve. This article first appeared on GuruFocus.
